Safety of Intravenous Thrombolysis for Wake-up Stroke
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose is to demonstrate the safety of intravenous tissue plasminogen activator (IV
t-PA) in ischemic stroke patients who present to the emergency department (ED) after
awakening with the symptoms of suspected ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston